催产素和阿片类药物对抗剂:改善社会行为的一种双重方法
Olga Dal Monte1,2, Prabaha Gangopadhyay3, Philip T Putnam4
1Department of Psychology, University of Turin, Torino, Italy.
Annals of the New York Academy of Sciences
|June 5, 2025
概括
催产素 (OT) 和阿片类系统相互作用,调节社会行为. 研究表明,将OT与阿片类药物抗剂结合起来可能会改善社会功能,但在精确的治疗应用方面仍然存在挑战.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 社会行为 社交行为
背景情况:
- 社会行为对心理健康至关重要,受神经调节系统的影响.
- 催产素 (OT) 是社会赤字干预的关键目标,但其影响是不一致的.
- 中央OT系统的复杂性来自与其他神经调节系统的相互作用.
研究的目的:
- 在社会行为调节中审查催产素 (OT) 和阿片类系统之间的关系.
- 探索调节这些相互作用系统的潜在治疗应用.
- 确定这一领域的研究挑战和未来方向.
主要方法:
- 文献综述侧重于OT和阿片类系统之间的相互作用.
- 对联合OT和阿片类药物抗剂效应的最新研究进行分析.
- 讨论用于精确调制的先进神经科学技术.
主要成果:
- OT和阿片类药物系统之间的相互作用显著影响社会行为.
- 新兴研究表明,OT和阿片类抗剂的联合管理有望改善社会功能.
- 挑战包括保持系统平衡,理解现实世界的背景,并实现精确的调制.
结论:
- 了解OT和阿片类药物系统之间的复杂相互作用对于开发有效的社会行为疗法至关重要.
- 需要先进的技术来精确地针对这些系统,以获得治疗效益.
- 需要进一步的研究来克服当前的挑战,并将发现转化为临床应用.
相关概念视频
Operant Conditioning Intervention
124
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
124
Neurotransmitters
1.5K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
1.5K
Combined Effects of Drugs: Antagonism
9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Drug-Receptor Interaction: Antagonist
3.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.5K
Drug-Receptor Interaction: Agonist
2.9K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.9K
Opioid Receptors: Overview
2.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.0K


